Sal-like 4 protein levels in breast cancer cells are post-translationally down-regulated by tripartite motif–containing 21

• Published in: The Journal of biological chemistry 2018-04, Vol.293 (17), p.6556-6564
• Main Authors: Itou, Junji, Li, Wenzhao, Ito, Shinji, Tanaka, Sunao, Matsumoto, Yoshiaki, Sato, Fumiaki, Toi, Masakazu
• Format: Article
• Language: English
• Subjects: breast cancer; Breast Neoplasms - genetics; Breast Neoplasms - metabolism; Down-Regulation; E3 ubiquitin ligase; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; MCF-7 Cells; molecular biology; Neoplasm Proteins - genetics; Neoplasm Proteins - metabolism; protein degradation; Protein Synthesis and Degradation; Proteolysis; Ribonucleoproteins - genetics; Ribonucleoproteins - metabolism; Ro52; SALL family; SALL4; transcription factor; Transcription Factors - biosynthesis; Transcription Factors - genetics; TRIM21
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.RA117.000245

Sal-like 4 (SALL4) is a transcription factor that enhances proliferation and migration in breast cancer cells. SALL4 expression therefore has the potential to promote cancer malignancy. However, the regulatory mechanisms involved in SALL4 protein expression have not been thoroughly elucidated. In this study, we observed that treating MCF-7 and SUM159 breast cancer cell lines with a proteasome inhibitor increases SALL4 protein levels, suggesting that SALL4 is degraded by the ubiquitin–proteasome system. Using immunoprecipitation to uncover SALL4-binding proteins, we identified an E3 ubiquitin-protein ligase, tripartite motif–containing 21 (TRIM21). Using an EGFP reporter probe of the major SALL4 isoform SALL4B, we observed that shRNA-mediated knockdown of TRIM21 increases cellular SALL4B levels. Immunostaining experiments revealed that TRIM21 localizes to the nucleus, and a K64R substitution in the nuclear localization motif in SALL4B increased SALL4B levels in the cytoplasm. These results suggested that TRIM21 is involved in nuclear SALL4 degradation. To identify the amino acid residue that is targeted by TRIM21, we fragmented the SALL4B sequence, fused it to EGFP, and identified Lys-190 in SALL4B as TRIM21’s target residue. Amino acid sequence alignments of SALL family members indicated that the region around SALL4 Lys-190 is conserved in both SALL1 and SALL3. Because SALL1 and SALL4 have similar functions, we constructed a SALL1-EGFP probe and found that the TRIM21 knockdown increases SALL1 levels, indicating that TRIM21 degrades both SALL1 and SALL4. Our findings extend our understanding of SALL4 and SALL1 regulation and may contribute to the development of SALL4-targeting therapies.